1. Achufusi T.G.O., Sharma A., Zamora E.A., Manocha D. Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus. 2020;12(6):e8860. DOI: 10.7759/cureus.8860 2. Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI. The Human Microbiome and Its Impacts on Health. Int J Microbiol. 2020 Jun 12;2020:8045646. doi: 10.1155/2020/8045646. 3. Yoshii K., Hosomi K., Sawane K., Kunisawa J. Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity. Front Nutr. 2019;6:48. DOI: 10.3389/fnut.2019.00048 4. Martinez-Guryn K., Leone V., Chang E.B. Regional Diversity of the Gastrointestinal Microbiome. Cell Host Microbe. 2019;26(3):314–24. DOI: 10.1016/j. chom.2019.08.011 5. Wu W., Chen F., Liu Z., Cong Y. Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22(6):1473–82. DOI: 10.1097/MIB.0000000000000775 6. Behnsen J., Jellbauer S., Wong C.P., Edwards R.A., George M.D., Ouyang W., Raffatellu M. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity. 2014;40(2):262–73. DOI: 10.1016/j.immuni.2014.01.003 7. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10(3):159–69. DOI: 10.1038/nri2710 8. Cash H.L., Whitham C.V., Behrendt C.L., Hooper L.V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313(5790):1126–30. DOI: 10.1126/science.1127119 9. Everard A., Lazarevic V., Gaïa N., Johansson M., Ståhlman M., Backhed F., et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014;8(10):2116–30. DOI: 10.1038/ismej.2014.45 10. Denning T.L., Sitaraman S.V. Segmented filamentous bacteria shape intestinal immunity. Gastroenterology. 2010;139(1):351–3. DOI: 10.1053/j.gastro.2010.05.032 11. Sachdev A.H., Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013;4(5):223–31. DOI: 10.1177/2040622313496126 12. Pyleris E., Tzivras D., Barbatzas C., Giamarellos-Bourboulis E.J., Koussoulas V., Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by 28 small bowel culture: Relationship with irritable bowel syndrome. Dig Dis Sci. 2012:57(5):1321–9. DOI: 10.1007/ s10620-012-2033-7 13. Leite G., Morales W., Weitsman S., Celly S., Parodi G., Mathur R., et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth. PLoS One. 15(7):e0234906. DOI: 10.1371/journal.pone.0234906 14. Takakura W., Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome — An Update. Front Psychiatry. 2020;11:664. DOI: 10.3389/fpsyt.2020.00664 15. Ghoshal U.C. How to interpret hydrogen breath tests. J Neurogastroenterol Motil. 2011;17(3):312–7. DOI: 10.5056/jnm.2011.17.3.312 16. Gandhi A., Shah A., Jones M.P., Koloski N., Talley N.J., Morrison M., Holtmann G. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis. Gut Microbes. 2021;13(1):1933313. DOI:10.1080/19490976.2021.1933313 17. Ghashghaeinia M., Mrowietz U. Human erythrocytes, nuclear factor kappaB (NFκB) and hydrogen sulfide (H2 S) — from non-genomic to genomic research. Cell Cycle. 2021;20(20):2091–101. DOI: 10.1080/15384101.2021 .1972557 18. Suri J., Kataria R., Malik Z., Parkman H.P., Schey R. Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit. Medicine (Baltimore). 2018 May;97(21):e10554. DOI: 10.1097/MD.0000000000010554 19. Bures J., Cyrany J., Kohoutova D., Förstl M., Rejchrt S., Kvetina J., et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978–90. DOI: 10.3748/wjg.v16.i24.2978 20. Montoro-Huguet M.A., Belloc B., Domínguez-Cajal M. Small and Large Intestine (I): Malabsorption of Nutrients. Nutrients. 2021;13(4):1254. DOI: 10.3390/nu13041254 21. Gabbard S.L., Lacy B.E., Levine G.M., Crowell M.D. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci. 2014;59(3):638–44. DOI: 10.1007/s10620-013-2960-y 22. Lakhani S.V., Shah H.N., Alexander K., Finelli F.C., Kirkpatrick J.R., Koch T.R. Small intestinal bacterial overgrowth and thiamine deficiency after Roux En-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28(5):293–8. DOI: 10.1016/j.nutres.2008.03.002 23. Parlesak A., Klein B., Schecher K., Bode J.C., Bode C. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc. 2003;51(6):768–73. DOI: 10.1046/j.1365-2389.2003.51259.x 29 24. Maslennikov R., Pavlov C., Ivashkin V. Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis? Turk J Gastroenterol. 2019;30(11):964– 75. DOI: 10.5152/tjg.2019.18551 25. Ivashkin K.V., Grechishnikova V.R., Reshetova M.S., Ivashkin V.T. Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(1):54–63 (In Russ.). DOI: 10.22416/1382-4376-2021-31-1-54-63 26. Jones R.M., Neish A.S. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol. 2011;13(5):670–6. DOI: 10.1111/j.1462-5822.2011.01579.x 27. Shah A., Morrison M., Burger D., Martin N., Rich J., Jones M., et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49(6):624–35. DOI: 10.1111/apt.15133 28. Polkowska-Pruszyńska B., Gerkowicz A., Szczepanik-Kułak P., Krasowska D. Small intestinal bacterial overgrowth in systemic sclerosis: a review of the literature. Arch Dermatol Res. 2019;311(1):1–8. DOI: 10.1007/ s00403-018-1874-0 29. Patil A.D. Link between hypothyroidism and small intestinal bacterial overgrowth. Indian J Endocrinol Metab. 2014;18(3):307–9. DOI: 10.4103/2230-8210.131155 30. Feng X., Li X.Q. The prevalence of small intestinal bacterial overgrowth in diabetes mellitus: a systematic review and meta-analysis. Aging (Albany NY). 2022;14(2): 975– 88. DOI: 10.18632/aging.203854 31. Lee A.A., Baker J.R., Wamsteker E.J., Saad R., DiMagno M.J. Small Intestinal Bacterial Overgrowth Is Common in Chronic Pancreatitis and Associates With Diabetes, Chronic Pancreatitis Severity, Low Zinc Levels, and Opiate Use. Am J Gastroenterol. 2019;114(7):1163–71. DOI: 10.14309/ajg.0000000000000200 32. Rao S.S.C., Tan G., Abdulla H., Yu S., Larion S., Leelasinjaroen P. Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)? Clin Transl Gastroenterol. 2018;9(4):146. DOI: 10.1038/ s41424-018-0011-x 33. Chander Roland B., Mullin G.E., Passi M., Zheng X., Salem A., Yolken R., Pasricha P.J. A Prospective Evaluation of Ileocecal Valve Dysfunction and Intestinal Motility Derangements in Small Intestinal Bacterial Overgrowth. Dig Dis Sci. 2017 34. Su T., Lai S., Lee A., He X., Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018;53(1):27– 36. DOI: 10.1007/s00535-017-1371-9 30 35. Reddymasu S.C., McCallum R.W. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol. 2010;44(1):e8–13. DOI: 10.1097/ MCG.0b013e3181aec746 36. Esposito S., Biscarini A., Federici B., Cofini M., Argentiero A., Neglia C., et al. Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children. Front Pediatr. 2020; 8:369. DOI: 10.3389/ fped.2020.00369 37. Hegade V.S., Speight .R.A, Etherington R.E., Jones D.E. Novel bile acid therapeutics for the treatment of chronic liver diseases. Therap Adv Gastroenterol. 2016;9(3): 376–91. DOI: 10.1177/1756283X16630712 38. El Kurdi B., Babar S., El Iskandarani M., Bataineh A., Lerch M.M., Young M., Singh V.P. Factors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-Regression. Clin Transl Gastroenterol. 2019;10(9):e00072. DOI: 10.14309/ctg.0000000000000072 39. Losurdo G., Marra A., Shahini E., Girardi B., Giorgio F., Amoruso A., et al. Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled data analysis. Neurogastroenterol Motil. 2017;29(6). DOI: 10.1111/nmo.13028 40. Choung R.S., Ruff K.C., Malhotra A., Herrick L., Locke G.R. 3rd, Harmsen W.S., Zinsmeister A.R., Talley N.J., Saito Y.A. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther. 2011;33(9):1059–67. DOI: 10.1111/j.1365- 2036.2011.04625.x 41. Erdogan A., Rao S.S., Gulley D., Jacobs C., Lee Y.Y., Badger C. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil. 2015;27(4):481–9. DOI: 10.1111/nmo.12516 42. Grace E., Shaw C., Whelan K., Andreyev H.J. Review article: small intestinal bacterial overgrowth-prevalence, clinical features, current and developing diagnostic tests, and treatment. Aliment Pharmacol Ther. 2013;38(7):674– 88. DOI: 10.1111/apt.12456 43. Maslennikov R., Pavlov C., Ivashkin V. Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis. Hepatol Int. 2018;12(6):567–76. DOI: 10.1007/s12072-018-9898-2 44. Song Y., Liu Y., Qi B., Cui X., Dong X., Wang Y., et al. Association of Small Intestinal Bacterial Overgrowth With Heart Failure and Its Prediction for Short-Term Outcomes. J Am Heart Assoc. 2021;10(7):e015292. DOI: 10.1161/JAHA.119.015292 45. Fadeeva M.V., Skhirtladze M.R., Ivashkin V.T. Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction. Russian Journal of Gastroenterology, Hepatology, 31 Coloproctology. 2019;29(3):38–48 (In Russ.) DOI: 10.22416/1382-4376-2019-29-3-38- 48 46. Potskhverashvili N.D., Zolnikova O.Yu., Kokina N.I., Dzhakhaya N.L., Sedova A.V., Bueverova E.L., Trukhmanov A.S. Small Bowel Bacterial Overgrowth Syndrome in Patients with Bronchial Asthma. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(4):47–54.(In Russ.) DOI: 10.22416/1382-4376- 2018-28-4-47- 54 47. Villette R., Kc P., Beliard S., Salas Tapia M.F., Rainteau D., Guerin M., Lesnik P. Unraveling HostGut Microbiota Dialogue and Its Impact on Cholesterol Levels. Front Pharmacol. 2020;11:278. DOI: 10.3389/ fphar.2020.00278 48. Gabbard S.L., Lacy B.E., Levine G.M., Crowell M.D. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci. 2014;59(3):638–44. DOI: 10.1007/s10620-013-2960-y 49. Miazga A., Osiński M., Cichy W., Żaba R. Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Adv Med Sci. 2015;60(1):118–24. DOI: 10.1016/j.advms.2014.09.001 50. Yokoyama K, Sakamaki A, Takahashi K, Naruse T, Sato C, Kawata Y, Tominaga K, Abe H, Sato H, Tsuchiya A, Kamimura K, Takamura M, Yokoyama J, Terai S. Hydrogenproducing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function. PLoS One. 2022 Feb 25;17(2):e0264459. doi: 10.1371/journal.pone.0264459. 51. Sorathia SJ, Chippa V, Rivas JM. Small Intestinal Bacterial Overgrowth. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK546634/ 52. Wang F.Y., Chi C.C. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut-Skin Axis of Rosacea. Adv Ther. 2021;38(3):1415–24. DOI: 10.1007/s12325-021-01624-x 53. Ghosh G., Jesudian A.B. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis. J Clin Exp Hepatol. 2019;9(2):257–67. DOI: 10.1016/j.jceh.2018.08.006 54. Pimentel M., Saad R.J., Long M.D., Rao S.S.C. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165–78. DOI: 10.14309/ ajg.0000000000000501 55. Ankar A., Kumar A. Vitamin B12 Deficiency. [Updated 2022 Oct 22]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK441923/ 32 56. Reddy P., Jialal I. Biochemistry, Fat Soluble Vitamins. [Updated 2022 Sep 19]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK534869/ 57. Marie I., Leroi A.M., Menard J.F., Leveнsque H., Quillard M., Ducrotte P. Fecal calprotectin in systemic sclerosis and review of the literature. Autoimmun Rev. 2015 Jun;14(6):547-54. doi: 10.1016/j.autrev.2015.01.018. 58. Ricci J.E.R. Júnior, Chebli L.A., Ribeiro T.C.D.R., Castro A.C.S., Gaburri P.D., Pace F.H.D.L., Barbosa K.V.B.D., Ferreira L.E.V.V.D.C., Passos M.D.C.F., Malaguti C., Delgado Á.H.D.A., Campos J.D., Coelho A.R., Chebli J.M.F. Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients. J Clin Gastroenterol. 2018 Jul;52(6):530-536. doi: 10.1097/MCG.0000000000000803. 59. Khoshini R., Dai S.C., Lezcano S., Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53(6):1443–54. DOI: 10.1007/s10620-007-0065-1 60. Ivashkin V.T., Medvedev O.S., Poluektova E.A., Kudryavtseva A.V., Bakhtogarimov I.R., Karchevskaya A.E. Direct and Indirect Methods for Studying Human Gut Microbiota. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(2):19-34. https://doi.org/10.22416/1382-4376-2022-32-2-19-34 61. Tang Q., Jin G., Wang G., Liu T., Liu X., Wang B., Cao H. Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices. Front Cell Infect Microbiol. 2020;10(151). DOI: 10.3389/fcimb.2020.00151 62. Kastl A.J. Jr, Terry N.A., Wu G.D., Albenberg L.G. The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. Cell Mol Gastroenterol Hepatol. 2020;9(1):33–45. DOI: 10.1016/j.jcmgh.2019.07.006 63. Greenson J.K. The biopsy pathology of non-coeliac enteropathy. Histopathology. 2015;66(1):29–36. DOI: 10.1111/ his.12522 64. Rao S.S.C., Bhagatwala J. Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management. Clin Transl Gastroenterol. 2019;10(10):e00078. DOI: 10.14309/ctg.0000000000000078 65. Rezaie A., Buresi M., Lembo A., Lin H., McCallum R., Rao S., et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017;112(5):775–84. DOI: 10.1038/ajg.2017.46 66. Hammer H.F., Fox M.R., Keller J., Salvatore S., Basilisco G., Hammer J., et al; European H2 -CH4 -breath test group. European guideline on indications, performance, and clinical 33 impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus. United European Gastroenterol J. 2022;10(1):15–40. DOI: 10.1002/ueg2.12133 67. Ivashkin V.T., Maev I.V., Abdulganieva D.I., Alekseeva O.P., Alekseenko S.A., Zolnikova O.Yu., Korochanskaya N.V., Medvedev O.S., Poluektova E.A., Simanenkov V.I., Trukhmanov A.S., Khlynov I.B., Tsukanov V.V., Shifrin O.S., Ivashkin K.V., Lapina T.L., Maslennikov R.V., Fadeeva M.V., Ulyanin A.I. Practical Recommendation of the Scientific Сommunity for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on Small Intestinal Bacterial Overgrowth in Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(3):68-85. https://doi.org/10.22416/1382-4376-2022-32-3-68-85 68. Simrén M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut. 2006 Mar;55(3):297- 303. doi: 10.1136/gut.2005.075127. PMID: 16474100; PMCID: PMC1856094. 69. Rosenthal A., Solomons N.W. Time-course of cigarette smoke contamination of clinical hydrogen breath-analysis tests. Clin Chem. 1983;29(11):1980–1. PMID: 6627640 70. Chang B.W., Chua K.S., Lin A.E., Chang C.. Understanding the significant interaction between hydrogen and methane in the performance and interpretation of breath testing. Gastroenterology 2015;148:S-729. DOI:10.1016/S0016-5085(15)32493-8 71. Gatta L., Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45(5):604–16. DOI: 10.1111/apt.13928 72. Castiglione F., Rispo A., Di Girolamo E., Cozzolino A., Manguso F., Grassia R., Mazzacca G. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther. 2003;18 (11–12):1107–12. DOI: 10.1046/j.1365-2036.2003.01800.x 73. Sajjad A., Mottershead M., Syn W.K., Jones R., Smith S., Nwokolo C.U. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2005; 74. Attar A., Flourié B., Rambaud J.C., Franchisseur C., Ruszniewski P., Bouhnik Y. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology. 1999;117(4):794–7. DOI: 10.1016/s0016- 5085(99)70336-7 34 75. Ghoshal U.C., Srivastava D., Misra A., Ghoshal U. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without smallintestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial. Eur J Gastroenterol Hepatol. 2016;28(3):281–9. DOI: 10.1097/ MEG.0000000000000557 76. Ivashkin V.T., Maev I.V., Abdulganieva D.I., Alekseenko S.A., Gorelov A.V., Zakharova I.N., Zolnikova O.Yu., Ivashkina N.Yu., Korochanskaya N.V., Mammayev S.N., Poluektova E.A., Trukhmanov A.S., Usenko D.V., Uspensky Yu.P., Tsukanov V.V., Shifrin O.S., Berezhnaya I.V., Ivashkin K.V., Lapina T.L., Maslennikov R.V., Nikolaeva S.V., Sugyan N.G., Ulyanin A.I. Practical Recommendations of Scientific Society for the Study of Human Microbiome and the Russian Gastroenterological Association on Use of Probiotics, Prebiotics, Synbiotics and Functional Foods in Treatment and Prevention of Gastroenterological Diseases in Children and Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(2):65-91. (In Russ.) https://doi.org/10.22416/1382-4376-2021-31-2-65-91 77. Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open. 2021 Aug 12;11(8):e043054. doi: 10.1136/bmjopen-2020-043054 78. Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4 79. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015 Oct;42(7):793-801. doi: 10.1111/apt.13344. 80. Pimentel M., Constantino T., Kong Y., Bajwa M., Rezaei A., Park S. A 14-day elemental diet is highly effective in normalizing the lactulose breath test. Dig Dis Sci. 2004;49(1):73–7. DOI: 10.1023/b:ddas.0000011605.43979.e1 81. Lauritano E.C., Gabrielli M., Scarpellini E., Lupascu A., Novi M., Sottili S., et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol. 2008;103(8):2031–5. DOI: 10.1111/j.1572-0241.2008.02030.x